An update on biological treatment of behavioral and psychological signs and symptoms of dementia;Les therapeutiques biologiques des signes et symptomes comportementaux et psychologiques de la demence: Mise au point et perspectives

Encephale

Volumn 26, Issue 3, 2000, Pages 72-80

  Gallarda, T ^a   Olie, J P ^a  

^a Service Hospitalo   (France)

Author keywords

Acetylcholinesterase inhibitor; Alzheimer's disease; Behavioral disturbances; Dementia; Frontal lobe dementia; Psychotropic drug

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; IPRONIAZID; LITHIUM CARBONATE; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; VILOXAZINE;

AGGRESSIVENESS; AGITATION; ALZHEIMER DISEASE; ANTICONVULSANT THERAPY; ANXIETY; BEHAVIOR DISORDER; DEMENTIA; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMAN; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; AGED; PSYCHOLOGICAL ASPECT; SOCIOPATHY; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; DEMENTIA; HUMANS; SOCIAL BEHAVIOR DISORDERS; TREATMENT OUTCOME;

EID: 0033928905     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. ALLAIN H et al. Effectiveness of tiapride in behavioral disorders of demented elderly. Europ Psychiatry 1998 ; 13 (Suppl 4) : 275S.
2. AMADO-BOCCARA I, GOUGOULIS N, POIRIER-LITTRE MF et al. Incidence des antidépresseurs sur les fonctions cognitives. Revue de la littérature. Encephale 1994 ; XX : 65-70.
3. AZORIN JM. Traitement du dément déprimé ou du déprimé dément. Encephale 1994 ; XX : 281-4.
4. BALLARD C, GRACE J, Mc KEITH I et al. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998 ; 351 (9108) : 1032-3.
5. BURKE WJ, FOLKS DG, ROCCAFORTE WH et al. Serotonin reuptake inhibitors for the treatment of coexisting depression and psychosis in dementia of Alzheimer type. Am J Geriatr Psychiatry 1995 ; 2 : 352-4.
6. CLEMENT JP, LEGER JM. La place des antidépresseurs dans la prise en charge des sujets déments. Encephale 1995 ; 21, Sp IV : 43-9.
7. COCCARO EF, KRAMER E, ZEMISHLANY Z et al. Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am J Psychiatry 1990 ; 147 : 1640-56.
8. CUMMINGS JL, MEGA MS et al. The neuropsychiatric inventory : comprehensive assessment of psychopathology in dementia. Neurology 1994 ; 41 : 1374-82.
9. CUMMINGS JL, BACK C. The cholinergic hypothesis of neuropsychiatrie symptoms in Alzheimer's disease. Am J Geriatric Psychiatry 1998 ; 6 (2) (Suppl 1) : S64-S78.
10. DELAY J. Les dérèglements de l'humeur. Paris : PUF, 1946.
11. DEVANAND DP, SACKEIM HA, BROWN RP et al. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. Arch Neurol 1989 ; 46 : 854-7.
12. DEVANAND DP, JACOBS DM, TANG MX et al. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 1997 ; 54 : 257-63.
13. DEVANAND DP, MARDER K, MICHAELS KS et al. A randomized, placebo controlled dose comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 1998 ; 155 (11) : 1512-20.
14. DOODY RS, PRATT R, PERDOMO C et al. Clinical benefits of donepezil : results from a long-term phase III extension trial. Neurology 1999 ; 52 (Suppl 2) : A-174.
15. th meeting of the European Neurological Society, Milan, Italy, 5-9 June 1999.
16. EASTWOOD R, REISBERG B. Mood and behavior. In : Gauthier S, ed. Clinical Diagnosis and Management of Alzheimer's Disease. Martin Dunitz, 1996 ; 175-89.
17. FAHS H, POTIRON G, SENON JL et al. Thymorégulateurs dans l'agitation et les troubles du comportement chez le sujet dément : à propos de huit cas. Encephale 1999 ; XXV : 169-74.
18. FINKEL SI, COSTA E SILVA J, COHEN GD et al. Behavioral and psychological symptoms of dementia. A consensus statement on current knowledge and implications for research and treatment. Am J Geriatr Psychiatry 1998 ; 6 (2) : 97-100.
19. GALLARDA T, MILLET B. Echelles d'anxiété. In : Michel BF, Touchon J, Pancrazi MP, Verdier JM, eds. Affect-Amygdale-Alzheimer. Manifestations non cognitives et diagnostic précoce des démences. Sola 1999 ; 129-39.
20. GALLARDA T. Maladie d'Alzheimer et dépression. Encephale 1999 ; Sp V : 14-8.
21. GALLARDA T, de CARVALHO W. Place de l'électroconvulsivothérapie dans le traitement de la dépression et de la démence. Rev Fr Psychiatr Psychol Med 1999 ; 27 : 62-6.
22. GALLARDA T. Les troubles psycho-comportementaux de la maladie d'Alzheimer. In : Le psychiatre face à la maladie d'Alzheimer. Synapse 1999 ; 155 : 66-8.
23. nd edition. American Psychiatric Press 1998 : 251-70.
24. GUTZMANN H, KUHL KP, KANOWSKI S et al. Measuring the efficacy of psychopharmacology treatment of psychomotric restlessness in dementia : clinical evaluation of tiapride. Pharmacopsychiatry 1997 ; 30(1) : 6-11.
25. HANTOUCHE E, PIAU A, LOO H. Quels antidépresseurs pour le dément et le sujet âgé ? In : Forette F, ed. Démences et dépressions. Paris : Maloine, 1989 : 122-45.
26. IVANOIU A, VANDERLINDEN M, SERON X et al. The effect of donepezil on memory and attention tests in Alzheimer's disease, American Academy of Neurology. Neurology 1999 ; 52 (Suppl 2) : A-482-A483.
27. JANOWSKY DS, OVERSTREET DH. The role of acetylcholine mechanisms in mood disorders. In : Bloom FE, Kupfer DJ, eds. Psychopharmacology : the Fourth Generation of Progress. New York : 1995 : 945-56.
28. KATONA CL, HUNTER BN, BRAY J. A double blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. Intern J Geriatr Psychiatry 1998 ; 13 : 100-8.
29. KATZ IR, JESTE DV, MINTZER JE et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia : a randomized, double blind trial. J Clin Psychiatry 1999 ; 60 : 107-15.
30. KAUFER DI, CATT K, POLLOCK BG et al. Donepezil in Alzheimer's disease : relative cognitive and neuropsychiatric responses and impact on caregiver distress. Neurology 1998 ; 50 (Suppl 4) : A 89.
31. KAUFER DI. Core neuropsychiatric symptom response profile to cholinergic therapy in Alzheimer's disease : clinical and neurobehavioral relevance. Neurology 1999 ; 52 (Suppl 2) : A-182.
32. KNEGTERING H, EIJCK M, HUIJSMAN A. Effects of antidepressants on cognitive functioning of elderly patients. Drugs Aging 1994 ; 5 : 192-9.
33. LAVRETSKY H, SULTZER D. A structured trial of risperidone for the treatment of agitation in dementia. Am J Geriatr Psychiatry 1998 ; 6 (2) : 127-35.
34. LEBERT F, PASQUIER F, PETIT H. Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatr 1994 ; 55 : 536-8.
35. LEBERT F, PASQUIER F, PETIT H. Behavioral effects of fluoxetine in dementia of Alzheimer type. Intern J Geriatr Soc 1994 ; 9 : 590-1.
36. LEBERT F, PASQUIER F. Neurobiologie et Pharmocologie. In : Pasquier F, Lebert F, eds. Les démences fronto-temporales, Congrès de Psychiatrie et de Neurologie de langue française. Paris : Masson, 1995 : 63-6.
37. LEBERT F, PASQUIER F. Démence et dépression : place des antidépresseurs et des thymorégulateurs. Rev Fr Psychiatr Psychol Med 1999 ; 27 : 56-8.
38. LEGER D, ROGER M, GERARD D. Sommeil et rythme de vie d'une population de personnes âgées insomniaques. Rev Geriatr 1998 ; 23 (1) : 1-11.
39. LEVY ML, CUMMINGS JL, KAHN-ROSE R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology 1999 ; 45 (Suppl 1) : 15-22.
40. LYKETSOS CG, STEELE C, GALIK E et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999 ; 156 (1) : 66-71.
41. MEGA MS, CUMMINGS JL, FIORELLOT et al. The spectrum of behavioral changes in Alzheimer disease. Neurology 1996 ; 46 : 130-5.
42. MICHEL BF, PANCRAZI-BOYER MP, ESTADIEU MC et al. Traitements médicamenteux des démences. In : Léger JM, Clément JP, Wertheimer J, eds. Psychiatrie du sujet âgé. Paris : Flammarion, Médecine-Sciences, 1999 : 374-92.
43. NOAGHIUL S, NARAYAN M, NELSON JC. Divalproex treatment of mania in elderly patients. Am J Geriatr Psychiatry 1998 ; 6 (3) : 257-62.
44. NYTH AL, GOTTFRIES CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic Multicentre study. Br J Psychiatry 1990 ; 157 : 894-901.
45. RASKIND MA, PESKIND ER. Treatment of non cognitive symptoms in Alzheimer's disease and other dementias. In : Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Washington : American Psychiatric Press, 1998 : 791-801.
46. REGAN WM, GORDON SM. Gabapentin for behavioral agitation in Alzheimer's disease, letter to the editor. J Clin Psychopharmacol 1997 ; 17(1) : 59-60.
47. REIFLER BV, TERI L, RASKIND M et al. Double blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989 ; 146 : 45-9.
48. RISSE SC, CUBBERLY L, LAMPE TH et al. Acute effects of neuroleptic withdrawal in elderly dementia patients. J Geriatr Drug Therap 1987 ; 2 : 65-7.
49. ROBERT PH, MEDECIN I, VINCENT S et al. Inventaire neuropsychiatrique : validation de la version française d'un instrument destiné à évaluer les troubles du comportement chez les sujets déments. Mal Alzheimer 1998 ; 5 : 63-86.
50. ROBERT PH, MEDECIN I. Behavioral abnormalities in Alzheimer's disease. Ann Med Interne 1998 ; 149 (4) : 216-20.
51. nd Annual Meeting of the American Psychiatric Association (APA), Washington DC, USA, 15-20 may, 1999.
52. ROSS JS, SHUA-HAUIM JR. Aricept-induced nigthmares in Alzheimer's disease : 2 case reports. Neurology 1998 ; 46 : 119-20.
53. ROTH M, MOUNTJOY CQ, AMREIN R. Effects of moclobemide on depressive symptoms and cognitive performance in geriatric population : a controlled comparative study versus placebo. Br J Psychiatry 1996 ; 168 : 149-57.
54. SCHINDLER RJ. Behavioral problems in Alzheimer's disease : general principles of pharmacotherapy. Am Acad Neurol 1999.
55. SCHNEIDER LS, POLLACK VE, LYNESS SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990 ; 38 : 553-63.
56. SMALL GW, RABINS PV, BARRY PP et al. Diagnosis and treatment of Alzheimer's disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatrics Society. JAMA 1997 ; 278 : 1363-71.
57. STERN RG, DUFFELMEYER ME, ZEMISHLANI Z et al. The use of benzodiazepines in the management of behavioral symptoms in demented patients. Psychiatr Clin North Am 1991 ; 14 : 375-84.
58. STREET J, CLARK SW, MITAN S et al. Olanzapine in the treatment of psychiatric disturbances associated with Alzheimer's disease. Neurology 1999 ; 52, 6 (Suppl 2) : A-396-7.
59. SWARTZ JR, MILLER BL, LESSER IM et al. Frontotemporal dementia : treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997 ; 58 : 212-6.
60. TARIOT PN, ERB R, PODGORSKI CA et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998 ; 155 : 54-61.
61. VANELLE JM, OLIE JP. Démence et dépression : la réponse sismothérapique. In : Forette F, ed. Démences et dépressions, Fondation Nationale de Gérontologie. Paris : Maloine, 1989 : 154-62.
62. VOLICER L, RHEAUME Y, CYR D. Treatment of depression in advanced Alzheimer's disease using sertraline. J Geriatr Psychiatry Neurol 1994 ; 7 : 227-9.
63. WEILER PG, MUNGAS D, BERNICK C. Propranolol for the control of disruptive behavior in senile dementia. J Geriatr Psychiatry Neurol 1988 ; 145 : 226-30.